Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Launched by INDIANA UNIVERSITY · Oct 5, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how certain lifestyle activities, like computerized brain training and Tai Chi-Qi Gong, can help people with early-onset Alzheimer's disease. Researchers want to see if these activities can improve thinking skills, daily functioning, and mood in participants compared to those who are not doing the training.
To join the study, participants should be between 40 and 64 years old, fluent in English, and in good health without other serious neurological conditions. They also need to be part of a larger study on early-onset Alzheimer's and have a support person who can help them. Participants can expect to engage in training sessions and assessments related to their cognitive health. It's important to note that having regular internet access for at least four hours a week is required to participate. This study aims to gather valuable information that could lead to new ways to support individuals with early-onset Alzheimer's disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled in the Longitudinal Early-Onset AD Study (LEADS) parent study, and being classified via LEADS consensus criteria as having amyloid-positive Early Onset Alzheimer's Disease
- • Aged 40-64 years at the time of enrollment into LEADS
- • Fluent in English
- • In good general health and absent another neurological disorder
- • Have a knowledgeable informant.
- • Have had a Clinical Dementia Rating scale of 0.5 to 1.0 at the time of enrollment into LEADS
- • Have sufficient vision, hearing, comprehension, and manual dexterity to participate in the testing and training program
- Exclusion Criteria:
- • • Have access to the internet (e.g., home, family, public library, etc.) for less than 4 hours per week
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Dustin B Hammers, PhD
Principal Investigator
Indiana University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials